"Receptors, Fc" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules.
| Descriptor ID |
D011961
|
| MeSH Number(s) |
D12.776.543.750.705.871
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Fc".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Fc".
This graph shows the total number of publications written about "Receptors, Fc" by people in this website by year, and whether "Receptors, Fc" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 1 | 1 |
| 2006 | 2 | 1 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Fc" by people in Profiles.
-
Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor. Mod Pathol. 2024 Mar; 37(3):100426.
-
A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia. Blood Adv. 2023 02 14; 7(3):396-405.
-
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS Pathog. 2022 01; 18(1):e1010179.
-
Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell. 2021 10 28; 184(22):5593-5607.e18.
-
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell. 2021 08 19; 184(17):4430-4446.e22.
-
Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials. Pediatr Blood Cancer. 2020 11; 67(11):e28630.
-
A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice. PLoS Pathog. 2020 08; 16(8):e1008743.
-
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes. Am J Hematol. 2019 07; 94(7):741-750.
-
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia. Haematologica. 2019 11; 104(11):2283-2291.
-
Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature. 2018 05; 557(7706):570-574.